Bio-Techne Corp (FRA:TE1)
€ 76.5 1 (1.32%) Market Cap: 11.96 Bil Enterprise Value: 12.28 Bil PE Ratio: 65.48 PB Ratio: 6.45 GF Score: 92/100

Bio-Techne Corp at Stifel Healthcare Conference (Virtual) Transcript

Nov 16, 2021 / 03:00PM GMT
Release Date Price: €109 (-0.46%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

Okay. Welcome back, everyone, to the Life Sciences and Diagnostics track for the 2021 Stifel Healthcare Conference. Up with us next is Bio-Techne, and we're happy to have CFO, Jim Hippel, with us. Jim, thanks for joining us today.

James T. Hippel
Bio-Techne Corporation - Executive VP of Finance & CFO

Yes, Dan. Thanks for having me.

Questions & Answers

Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst

My pleasure. Maybe just to start, Jim, can you just touch on the key takeaways coming out of the quarter, the end market conditions that you're looking at and then just the supply chain concerns have been asked on every tools call this quarter. They were asked on yours. It doesn't sound like really across the board, there are too many companies that are dealing with anything too significant. But it would be great just to sort of hear

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot